These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 19800180)

  • 41. Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma.
    Martin JM; Rosewall T; Bayley A; Bristow R; Chung P; Crook J; Gospodarowicz M; McLean M; Ménard C; Milosevic M; Warde P; Catton C
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1084-9. PubMed ID: 17606331
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer.
    Greven K; Winter K; Underhill K; Fontenesci J; Cooper J; Burke T;
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):168-73. PubMed ID: 15093913
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pathologic stage I-II endometrial carcinoma in the elderly: radiotherapy indications and outcome.
    Citron JR; Sutton H; Yamada SD; Mehta N; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1432-8. PubMed ID: 15275729
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer.
    Schwarz M; Alber M; Lebesque JV; Mijnheer BJ; Damen EM
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):561-70. PubMed ID: 15890601
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost.
    Freedman GM; Anderson PR; Goldstein LJ; Ma CM; Li J; Swaby RF; Litwin S; Watkins-Bruner D; Sigurdson ER; Morrow M
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):347-53. PubMed ID: 17379430
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1).
    Ferro M; Chiesa S; Macchia G; Cilla S; Bertini F; Frezza G; Farioli A; Cammelli S; Balducci M; Ianiro A; Angelini AL; Compagnone G; Valentini V; Deodato F; Morganti AG
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):82-90. PubMed ID: 27843034
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial.
    Macchia G; Cilla S; Deodato F; Ianiro A; Legge F; Marucci M; Cammelli S; Perrone AM; De Iaco P; Gambacorta MA; Autorino R; Valentini V; Morganti AG; Ferrandina G
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):606-13. PubMed ID: 27681755
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Maximum tolerated dose in a phase I trial on adaptive dose painting by numbers for head and neck cancer.
    Madani I; Duprez F; Boterberg T; Van de Wiele C; Bonte K; Deron P; De Gersem W; Coghe M; De Neve W
    Radiother Oncol; 2011 Dec; 101(3):351-5. PubMed ID: 21742392
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phase I trial of simultaneous in-field boost with helical tomotherapy for patients with one to three brain metastases.
    Rodrigues G; Yartsev S; Yaremko B; Perera F; Dar AR; Hammond A; Lock M; Yu E; Ash R; Caudrelier JM; Khuntia D; Bailey L; Bauman G
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1128-33. PubMed ID: 20675078
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A phase I dose-escalation trial of stereotactic body radiotherapy using 4 fractions for patients with localized prostate cancer.
    Kainuma T; Kawakami S; Tsumura H; Satoh T; Tabata KI; Iwamura M; Hayakawa K; Ishiyama H
    Radiat Oncol; 2019 Sep; 14(1):158. PubMed ID: 31477122
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of post operative intensity modulated radiotherapy on acute gastro-intestinal toxicity for patients with endometrial cancer: results of the phase II RTCMIENDOMETRE French multicentre trial.
    Barillot I; Tavernier E; Peignaux K; Williaume D; Nickers P; Leblanc-Onfroy M; Lerouge D
    Radiother Oncol; 2014 Apr; 111(1):138-43. PubMed ID: 24630537
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Volumetric-modulated arc therapy with vaginal cuff simultaneous integrated boost as an alternative to brachytherapy in adjuvant irradiation for endometrial cancer: a prospective study.
    Alongi F; Mazzola R; Ricchetti F; Fersino S; Levra NG; Fiorentino A; Naccarato S; Sicignano G; Di Paola G; Ruggieri R; Gori S; Ceccaroni M
    Anticancer Res; 2015 Apr; 35(4):2149-55. PubMed ID: 25862871
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radiotherapy practices in postoperative endometrial cancer: A survey of the ABS membership.
    Martell K; Doll C; Barnes EA; Phan T; Leung E; Taggar A
    Brachytherapy; 2019; 18(6):741-746. PubMed ID: 31521546
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Evidence based medicine and high performance irradiation techniques: endometrial cancer].
    Jouglar E; Barillot I
    Cancer Radiother; 2014 Oct; 18(5-6):495-500. PubMed ID: 25155783
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute toxicity of postoperative IMRT and chemotherapy for endometrial cancer.
    Tierney RM; Powell MA; Mutch DG; Gibb RK; Rader JS; Grigsby PW
    Radiat Med; 2007 Nov; 25(9):439-45. PubMed ID: 18026901
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A phase II study of intensity modulated radiation therapy to the pelvis for postoperative patients with endometrial carcinoma: radiation therapy oncology group trial 0418.
    Jhingran A; Winter K; Portelance L; Miller B; Salehpour M; Gaur R; Souhami L; Small W; Berk L; Gaffney D
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):e23-8. PubMed ID: 22543211
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interfraction motion of the vaginal apex during postoperative intensity modulated radiation therapy: are we missing the target?
    Rash D; Hagar Y; Cui J; Hunt JP; Valicenti R; Mayadev J;
    Int J Gynecol Cancer; 2013 Feb; 23(2):385-92. PubMed ID: 23287959
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intensity modulated radiotherapy in gynecologic cancers: hope, hype or hyperbole?
    Wagner A; Jhingran A; Gaffney D
    Gynecol Oncol; 2013 Jul; 130(1):229-36. PubMed ID: 23632209
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potential proton beam therapy for recurrent endometrial cancer in the vagina.
    Yanazume S; Arimura T; Kobayashi H; Douchi T
    J Obstet Gynaecol Res; 2015 May; 41(5):813-6. PubMed ID: 25369803
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of stage 1 endometrial carcinoma. Postoperative radiotherapy is not justified in women with medium risk disease.
    Burger MP
    BMJ; 2001 Mar; 322(7286):568-9. PubMed ID: 11238140
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.